Clinical Trial Update: IMPELLA, Complications and Tolerance

View source ↗

Summary

A clinical trial update indicates that the IMPELLA device is being studied for cardiogenic shock and is currently recruiting at University Hospital, Montpellier…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Drugs mentioned

• Impella (Impella microaxial pump)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Cardiogenic Shock | Status: RECRUITING